APA aipamena

Okuma, Y., & Hosomi, Y. (2017). Osimertinib for advanced non-small cell lung cancer harboring EGFR mutation exon 20 T790M, acquired resistant mutation for first- or second-generation EGFR-TKI. J Thorac Dis.

Chicago Style aipamena

Okuma, Yusuke, and Yukio Hosomi. "Osimertinib for Advanced Non-small Cell Lung Cancer Harboring EGFR Mutation Exon 20 T790M, Acquired Resistant Mutation for First- or Second-generation EGFR-TKI." J Thorac Dis 2017.

MLA aipamena

Okuma, Yusuke, and Yukio Hosomi. "Osimertinib for Advanced Non-small Cell Lung Cancer Harboring EGFR Mutation Exon 20 T790M, Acquired Resistant Mutation for First- or Second-generation EGFR-TKI." J Thorac Dis 2017.